Searchable abstracts of presentations at key conferences in endocrinology

ea0029p40 | Adrenal cortex | ICEECE2012

The Wnt/Beta-catenin and Ras/Raf/MEK/ERK signaling pathways alterations in adrenocortical tumors

Rubin B. , Pezzani R. , Barollo S. , Mariniello B. , Salva M. , Iacobone M. , Fassina A. , Mantero F.

Adrenocortical tumors (ACT) include benign and malignant tumors. Adrenocortical carcinomas (ACC) are highly malignant neoplasms with a poor prognosis, but their genetic alterations to date identified are limited. Laboratory studies on ACT have revealed a wide variety of signaling pathways involved in these tumors, among these Wnt/β-catenin signaling pathway and Ras/Raf/MEK/ERK pathway resulted often disregulated. Another important factor in many signaling pathways is the ...

ea0029p825 | Endocrine tumours and neoplasia | ICEECE2012

Ouabain as an antiproliferative agent on adrenocortical cell models and on primary adrenocortical tumor cells

Pezzani R. , Rubin B. , Barollo S. , Redaelli M. , Mucignat-Caretta C. , Mantero F.

Ouabain is a cardiotonic steroid belonging to Strophanthus species. Recently its role in the treatment of tumors has been investigated, as ouabain seems to exert antiproliferative effects. Adrenocortical carcinoma (ACC) is a rare cancer, with poor prognosis, of which SW13 and H295R cells could be considered a cellular model.Our aim was to evaluate if ouabain exerts anticancer property.The effects of ouabain were assessed by MTT ass...